top of page
Researcher

ENACT-REACT COVID (MS)

Start Date:

March 2020

End Date:

March 2022

Duration:

24 months

ID-CARE Role:
Website:

Leader

Description

Title: Study of gut microbiome signatures in COVID-19.


Design: Longitudinal laboratory-based prospective study.


Primary Objective: to assess changes in the gut microbiome composition over time according to disease severity and treatment.


Secondary Objective: to find markers of microbiome composition correlated to immunological markers of infections; to assess changes in microbiome according to coinfections.

Partners
University of Verona
Sponsor
Horizon2020.jpg
Horizon2020.jpg
Horizon2020.jpg
Horizon2020.jpg
Publications

Microorganisms

09/01/24

Gut Microbiome Disruption Following SARS-CoV-2: A Review

ID-CARE Participants

Evelina Tacconelli

Director

From our Blog
In the News
LOGO IDCARE bianco.png
  • Twitter
  • LinkedIn

Borgo Roma-Policlinico G.B. Rossi, Piazzale Antonio Ludovico Scuro, 10, 37134, Verona, Italy.

Borgo Trento-Ospedale Borgo Trento Piazzale Aristide Stefani, 1 - 37126, Verona, Italy

+39 045 8128243

Copyright © 2024 ID-Care.

bottom of page